Abstract
The association between viral infection and autoimmune diseases is an established phenomenon in medicine. Hepatitis C viral infection is known to have such an association; however, its association with systemic lupus erythematosus has not been studied in a real life study driven from a large national database. The objective of this study was to investigate the association between SLE and chronic hepatitis C viral infection. Patients with SLE were compared with age- and sex-matched controls regarding the proportion chronic HCV infection. Chi-square and t tests were used for univariate analysis, and a logistic regression model was used for multivariate analysis. The study was performed utilizing the medical database of Clalit Health Services in Israel. There was a significant higher proportion of hepatitis C viral infection in SLE patients as compared to controls (1.06 and 0.39%, respectively; p < 0.001). A significant association was also observed among patients of higher socioeconomic status. In a multivariate logistic regression analysis, SLE was significantly associated with hepatitis C viral infection (OR = 2.07, 95% CI = 1.46–2.90). To conclude, Patients with SLE have a greater proportion of chronic HCV infection than matched controls.
Similar content being viewed by others
References
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21.
Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14(1):75–9.
Dahan S, Shor DB, Comaneshter D, Tekes-Manova D, Shovman O, Amital H, et al. All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev. 2016;15(8):848–53.
Shor DB, Dahan S, Comaneshter D, Cohen AD, Amital H. Does inflammatory bowel disease coexist with systemic lupus erythematosus? Autoimmun Rev 2016.
Tiosano S, Farhi A, Watad A, Grysman N, Stryjer R, Amital H et al. Schizophrenia among patients with systemic lupus erythematosus: population-based cross-sectional study. Epidemiol Psychiatr Sci 2016;1–6.
Watad A, Mahroum N, Whitby A, Gertel S, Comaneshter D, Cohen AD, et al. Hypothyroidism among SLE patients: case-control study. Autoimmun Rev. 2016;15(5):484–6.
Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H. Hyperthyroidism association with SLE, lessons from real-life data—a case-control study. Autoimmunity. 2016;49(1):17–20.
Harley JB, Harley IT, Guthridge JM, James JA. The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus. 2006;15(11):768–77.
James JA, Robertson JM. Lupus and Epstein-Barr. Curr Opin Rheumatol. 2012;24(4):383–8.
Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004;172(2):1287–94.
Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, et al. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci. 2009;1173:658–63.
Gendelman O, Mahroum N, Comaneshter D, Rotman-Pikielny P, Cohen AD, Amital H et al. Hepatitis B carrier state among SLE patients: case-control study. Immunol Res 2016.
Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten E, Kremer LC, et al. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet. 1995;345(8942):95–6.
Donahue JG, Munoz A, Ness PM, Brown Jr DE, Yawn DH, McAllister Jr HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992;327(6):369–73.
El SY, Hemida K, Rafik M, Al SR, Ali-Eldin ZA, GadAllah S. Detection of occult hepatitis C virus among healthy spouses of patients with HCV infection. J Med Virol. 2015;87(3):424–7.
Aykin N, Cevik F, Demirturk N, Demirdal T, Orhan S, Naz H. Anti-HCV positivity in sexual partners and offspring of patient with chronic hepatitis C. Scand J Infect Dis. 2008;40(6–7):533–7.
Mohd HK, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42.
Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med. 2011;364(25):2429–38.
Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52(RR-3):1–13, 15.
Amital H, Rubinow A, Langevitz P, Shoenfeld Y. Refractory leg infection as an inducer of the catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2004;63(8):1004.
Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol. 2008;26(1 Suppl 48):S27–32.
Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, et al. The role of infections in the immunopathogensis of systemic sclerosis—evidence from serological studies. Ann N Y Acad Sci. 2009;1173:627–32.
Barzilai O, Ram M, Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol. 2007;19(6):636–43.
Belizna CC, Hamidou MA, Levesque H, Guillevin L, Shoenfeld Y. Infection and vasculitis. Rheumatology (Oxford). 2009;48(5):475–82.
Plot L, Amital H, Barzilai O, Ram M, Bizzaro N, Shoenfeld Y. Infections may have a protective role in the etiopathogenesis of celiac disease. Ann N Y Acad Sci. 2009;1173:670–4.
Ram M, Shoenfeld Y. Hepatitis B: infection, vaccination and autoimmunity. Isr Med Assoc J. 2008;10(1):61–4.
Draborg AH, Jacobsen S, Westergaard M, Mortensen S, Larsen JL, Houen G, et al. Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients. Lupus Sci Med. 2014;1(1):e000015.
Filimonova RG, Bogomolova NN, Nevraeva EG, Tareyeva IE. Measles virus genome in patients with lupus nephritis and glomerulonephritis. Nephron. 1994;67(4):488–9.
Liu X, Jiao Y, Cui B, Gao X, Xu J, Zhao Y. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice. Lupus. 2016;25(11):1180–9.
Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M, et al. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev. 2008;7(8):621–5.
Palazzi C, D'Angelo S, Olivieri I. Hepatitis C virus-related arthritis. Autoimmun Rev. 2008;8(1):48–51.
Sousa GM, Oliveira RC, Pereira MM, Parana R, Sousa-Atta ML, Atta AM. Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin. Autoimmun Rev. 2011;10(4):210–3.
Rosenthal E, Cacoub P. Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus. 2015;24(4–5):469–82.
Krajewska M, Rukasz D, Jakuszko K, Augustyniak-Bartosik H, Penar J, Bednarz Z, et al. Hepatitis C-associated glomerulonephritis mimicking systemic lupus erythematosus. Scand J Rheumatol. 2015;44(4):343–4.
Ramos-Casals M, Garcia-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, et al. Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore). 2001;80(1):1–8.
Ramos-Casals M, Jara LJ, Medina F, Rosas J, Calvo-Alen J, Mana J, et al. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases. J Intern Med. 2005;257(6):549–57.
El GA, El ZB, Gheith R, Sheba H, Abdel MG, El GK. Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward. Rheumatol Int. 2012;32(9):2691–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the ethical committee of CHS, located at the Soroka Medical Center, Beer Sheva, Israel.
Rights and permissions
About this article
Cite this article
Mahroum, N., Hejly, A., Tiosano, S. et al. Chronic hepatitis C viral infection among SLE patients: the significance of coexistence. Immunol Res 65, 477–481 (2017). https://doi.org/10.1007/s12026-016-8886-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-016-8886-7